Time to potential for listing of new drugs on public and private formularies in Canada: a cross-sectional study

BACKGROUND: Information about the timing involved in various stages of making new drugs available to Canadians is important for understanding how a national pharmacare plan will affect timely access to new drugs. I explored the timing of the various steps between receiving a Notice of Compliance and...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671297/
https://www.ncbi.nlm.nih.gov/pubmed/36379586
http://dx.doi.org/10.9778/cmajo.20220063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671297/
https://www.ncbi.nlm.nih.gov/pubmed/36379586
http://dx.doi.org/10.9778/cmajo.20220063

Ejemplares similares